Development and validation of stability indicating RP-HPLC method for estimation of Perindopril Erbumine and Indapamide in bulk and pharmaceutical dosage form

https://doi.org/10.53730/ijhs.v6nS6.11703

Authors

  • Tabrej Mujawar Department of Pharmacology, Gangamai College of Pharmacy, Nagaon, Dist. Dhule, Affiliated to Kavayitri Bahinabai Chaudhari North Maharashtra University, Jalgaon, Maharashtra, India
  • Sufiyan Ahmad Department of Quality Assurance, Gangamai College of Pharmacy, Nagaon, Dist. Dhule, Affiliated to Kavayitri Bahinabai Chaudhari North Maharashtra University, Jalgaon, Maharashtra, India
  • Salman Khatik Department of Quality Assurance, Gangamai College of Pharmacy, Nagaon, Dist. Dhule, Affiliated to Kavayitri Bahinabai Chaudhari North Maharashtra University, Jalgaon, Maharashtra, India
  • Manoj Tare Department of Pharmaceutics, Sitabai Thite College of Pharmacy, Shirur (Ghodnadi), Affiliated to Savitribai Phule Pune University, Pune, Maharashtra, India
  • Dwarkadas Baheti Department of Pharmacognosy, Sitabai Thite College of Pharmacy, Shirur (Ghodnadi), Affiliated to Savitribai Phule Pune University, Pune, Maharashtra, India
  • Asmita Gaikwad Department of Pharmaceutical Chemistry, Sharadchandra Pawar College of Pharmacy, Otur, Tal. Junnar, Affiliated to Savitribai Phule Pune University, Pune, Maharashtra, India
  • Gauri Ghangale Department of Pharmacognosy, Amrutvahini College of Pharmacy, Sangamner, Dist. Ahmednagar, Affiliated to Savitribai Phule Pune University, Pune, Maharashtra, India

Keywords:

perindopril Erbumine, Indapamide, validation, stability, degradation, RP-HPLC

Abstract

Background: Perindopril erbumine (PE) and Indapamide (IND) in combination were proven to have a synergistic antihypertensive impact when compared with the use of each component alone. Objectives: Therefore, a new  simple,  selective, precise, and stability indicating RP- HPLC method for analysis of  Perindopril erbumine (PE) and Indapamide both in a bulk and in pharmaceutical formulation has been developed and validated. Methods: RP ‑ HPLC  method, Younglin (S.K.) Gradient System  UV Detector  and C18  column with 250mm  x 4.6 mm i. d. and 5μm particle size acetonitrile 70+  water with OPA 30 was used as the mobile phase for the method. The detection wavelength was 215 nm and flow rate was 1 ml/min. Results: In the developed method, the retention time of Perindopril erbumine (PE) and Indapamide were found to be 5.4833 min and 9.4500min. The developed method was validated according to the ICH guidelines. The linearity, precision, range, robustness was within the limits as specified by the ICH guidelines. Conclusion: Hence the method was found to be simple, accurate, precise, economic and reproducible. The forced degradation studies proved stability indicating power of the method. 

Downloads

Download data is not yet available.

References

ABDELLATEF, H. E. (1998). UTILITY OF CERTAIN Π-ACCEPTORS FOR THE SPECTROPHOTOMETRIC DETERMINATION OF PERINDOPRIL. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 17(8), 1267-1271. DOI: 10.1016/S0731-7085(97)00254-9

ABDELLATEF, H. E., AYAD, M. M., & TAHA, E. A. (1999). SPECTROPHOTOMETRIC AND ATOMIC ABSORPTION SPECTROMETRIC DETERMINATION OF RAMIPRIL AND PERINDOPRIL THROUGH TERNARY COMPLEX FORMATION WITH EOSIN AND CU (II). JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 18(6), 1021-1027. DOI: 10.1016/S0731-7085(98)00113-7.

ALBU, F., GEORGIŢĂ, C., DAVID, V., & MEDVEDOVICI, A. (2005). LIQUID CHROMATOGRAPHY–ELECTROSPRAY TANDEM MASS SPECTROMETRY METHOD FOR DETERMINATION OF INDAPAMIDE IN SERUM FOR SINGLE/MULTIPLE DOSE BIOEQUIVALENCE STUDIES OF SUSTAINED RELEASE FORMULATIONS. JOURNAL OF CHROMATOGRAPHY B, 816(1-2), 35-40. DOI: 10.1016/J.JCHROMB.2004.11.002.

AWATADE, P. R., VEER, V. S., KASABE, A. . J., & DHEPE, S. D. (2022). ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF RIVAROXABAN IN BULK AND PHARMACEUTICAL DOSAGE FORM BY USING RP-HPLC. INTERNATIONAL JOURNAL OF HEALTH SCIENCES, 6(S2), 14688–14702.

BRITISH PHARMACOPOEIA COMMISSION. BRITISH PHARMACOPOEIA; TSO: LONDON, UK, 2007; VOLUME II, PP. 1609-1611.

CHAFFMAN, M., HEEL, R. C., BROGDEN, R. N., SPEIGHT, T. M., & AVERY, G. S. (1984). INDAPAMIDE. DRUGS, 28(3), 189-235. DOI: 10.2165/00003495-198428030-00001

CROOM, K., KASSIANOS, G., SCHACHTER, M., MORRELL, J., GAW, A., KIRBY, M., ... & WALLER, D. (2008). COVERSYL PLUS-TREATING HYPERTENSION AND IMPROVING CLINICAL OUTCOMES IN T2D AND OTHER HIGH RISK GROUPS. DRUGS IN CONTEXT, 4(1), 71-84.

DE LEEUW, P. W. (2001). VERY-LOW-DOSE COMBINATION OF PERINDOPRIL AND INDAPAMIDE AS A NOVEL STRATEGY IN FIRST-LINE MANAGEMENT OF HYPERTENSION. JOURNAL OF HYPERTENSION. SUPPLEMENT: OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY OF HYPERTENSION, 19(3), S41-5.

DE LEEUW, P. W. (2011). COMBINATION PERINDOPRIL/INDAPAMIDE FOR THE TREATMENT OF HYPERTENSION: A REVIEW. EXPERT OPINION ON PHARMACOTHERAPY, 12(11), 1827-1833. DOI: 10.1517/14656566.2011.585638.

DEAN DA AND RHODES C T. DRUG STABILITY, PRINCIPLES AND PRACTICES, CARSTENSEN J, 3RD EDITION, NEW YORK: MARCEL DECER, INC. 2000, P 515.

ELSHANAWANE, A. A., MOSTAFA, S. M., & ELGAWISH, M. S. (2008). DEVELOPMENT AND VALIDATION OF LC METHOD FOR SIMULTANEOUS DETERMINATION OF TWO BINARY MIXTURES CONTAINING INDAPAMIDE. CHROMATOGRAPHIA, 67(9), 837-840. DOI:10.1365/S10337-008-0600-Z.

ERK, N. (2001). COMPARISON OF SPECTROPHOTOMETRIC AND AN LC METHOD FOR THE DETERMINATION PERINDOPRIL AND INDAPAMIDE IN PHARMACEUTICAL FORMULATIONS. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 26(1), 43-52. DOI: 10.1016/S0731-7085(01)00388-0.

FOOD AND DRUG ADMINISTRATION DRAFT GUIDANCE FOR INDUSTRY ON ANALYTICAL PROCEDURES AND METHODS VALIDATION 2000. CHEMISTRY, MANUFACTURING, AND CONTROLS DOCUMENTATION; AVAILABILITY, FED. REGIST, 65 (169), P. 52776–52777.

GAO, X., CHEN, J., MEI, N., TAO, W., JIANG, W., & JIANG, X. (2005). HPLC DETERMINATION AND PHARMACOKINETIC STUDY OF INDAPAMIDE IN HUMAN WHOLE BLOOD. CHROMATOGRAPHIA, 61(11), 581-585. HTTPS://DOI.ORG/10.1365/S10337-005-0548-1.

GRIMM W AND RHODES C T. DRUG STABILITY, PRINCIPLES AND PRACTICES, CARSTENSEN J, 3RD EDITION, NEW YORK: MARCEL DECER, INC. 2000, P 415.

Hafid, R. N. H., Baso, Y. S., Ramadany, S., Manapa, E. S., & Tamar, M. (2021). The difference of satisfaction level of midwifery students in trying out competency test with computer-based test and web-based test . International Journal of Health & Medical Sciences, 4(1), 8-14. https://doi.org/10.31295/ijhms.v4n1.390

HANG, T. J., ZHAO, W., LIU, J., SONG, M., XIE, Y., ZHANG, Z., ... & ZHANG, Y. (2006). A SELECTIVE HPLC METHOD FOR THE DETERMINATION OF INDAPAMIDE IN HUMAN WHOLE BLOOD: APPLICATION TO A BIOEQUIVALENCE STUDY IN CHINESE VOLUNTEERS. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 40(1), 202-205. DOI: 10.1016/J.JPBA.2005.06.035.

HTTPS://DOI.ORG/10.53730/IJHS.V6NS2.8879

ICH HARMONIZED TRIPARTITE GUIDELINE Q1F 2003.STABILITY DATA PACKAGE FOR REGISTRATION APPLICATIONS IN CLIMATIC ZONES III AND IV, LONDON.

INTERNATIONAL CONFERENCE ON HARMONISATION GUIDELINE ON VALIDATION OF ANALYTICAL PROCEDURES 1995. DEFINITIONS AND TERMINOLOGY; AVAILABILITY, FED. REGIST, 60 (40), P. 11260–11262.

INTERNATIONAL CONFERENCE ON HARMONISATION GUIDANCE FOR INDUSTRY, Q1A(R2) 2000. STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS, IFPMA. GENEVA.

JAIN, D. S., SUBBAIAH, G., SANYAL, M., PANDE, U. C., & SHRIVASTAV, P. (2006). FIRST LC–MS/MS ELECTROSPRAY IONIZATION VALIDATED METHOD FOR THE QUANTIFICATION OF PERINDOPRIL AND ITS METABOLITE PERINDOPRILAT IN HUMAN PLASMA AND ITS APPLICATION TO BIOEQUIVALENCE STUDY. JOURNAL OF CHROMATOGRAPHY B, 837(1-2), 92-100. DOI: 10.1016/J.JCHROMB.2006.04.008.

KALTA, R. R., SHARMA, R., & CHATURVEDI, S. C. (2008). SIMULTANEOUS RPHPLC DETERMINATION OF NITAZOXANIDE AND OFLOXACIN IN COMBINED TABLET DOSAGE FORM. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 70(4), 491. DOI: 10.4103/0250-474X.44600

LALITHA, N. A., PURANIK, S. B., & PAI, P. N. S. (2009). A STABILITY-INDICATING HPLC METHOD FOR CEFOPERAZONE. EURASIAN JOURNAL OF ANALYTICAL CHEMISTRY, 4(1), 110-118.

LEGORBURU, M. J., ALONSO, R. M., JIMENEZ, R. M., & ORTIZ, E. (1999). QUANTITATIVE DETERMINATION OF INDAPAMIDE IN PHARMACEUTICALS AND URINE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH AMPEROMETRIC DETECTION. JOURNAL OF CHROMATOGRAPHIC SCIENCE, 37(8), 283-287. DOI: 10.1093/CHROMSCI/37.8.283.

LIN, S. J., WU, H. L., CHEN, S. H., & WEN, Y. H. (1996). DERIVATIZATION-GAS CHROMATOGRAPHIC DETERMINATION OF PERINDOPRIL. ANALYTICAL LETTERS, 29(10), 1751-1762. HTTPS://DOI.ORG/10.1080/00032719608001521.

MANSIA, G., DE BACKER, G., DOMINICZAK, A., CIFKOVA, R., FAGARD, R., GERMANO, G., ... & EUROPEAN SOCIETY OF CARDIOLOGY. (2007). 2007 ESH-ESC GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION: THE TASK FORCE FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION OF THE EUROPEAN SOCIETY OF HYPERTENSION (ESH) AND OF THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC). BLOOD PRESSURE, 16(3), 135-232. DOI: 10.1097/01.HJH.0000431740.32696.CC

MEDENICA, M., IVANOVIĆ, D., MAŠKOVIĆ, M., JANČIĆ, B., & MALENOVIĆ, A. (2007). EVALUATION OF IMPURITIES LEVEL OF PERINDOPRIL TERT-BUTYLAMINE IN TABLETS. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 44(5), 1087-1094.

MOURAD, J. J., WAEBER, B., ZANNAD, F., LAVILLE, M., DURU, G., & ANDRÉJAK, M. (2004). COMPARISON OF DIFFERENT THERAPEUTIC STRATEGIES IN HYPERTENSION: A LOW-DOSE COMBINATION OF PERINDOPRIL/INDAPAMIDE VERSUS A SEQUENTIAL MONOTHERAPY OR A STEPPED-CARE APPROACH. JOURNAL OF HYPERTENSION, 22(12), 2379-2386.

NEDOGODA, S. V., & STOJANOV, V. J. (2017). SINGLE-PILL COMBINATION OF PERINDOPRIL/INDAPAMIDE/AMLODIPINE IN PATIENTS WITH UNCONTROLLED HYPERTENSION: A RANDOMIZED CONTROLLED TRIAL. CARDIOLOGY AND THERAPY, 6(1), 91-104. DOI: 10.1007/S40119-017-0085-7.

PANNU, H., MAHAJAN, M., & SAWANT, S. (2012). VALIDATED RP-HPLC METHOD FOR THE DETERMINATION OF INDAPAMIDE IN BULK AND TABLET DOSAGE FORM. DER PHARMA CHEM, 4, 996-1002.

PATE, A. N., BARGE, V., KASABE, A., KERLE, V., & KULKARNI, O. (2022). ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF DOLUTEGRAVIR IN TABLET DOSAGE FORM. INTERNATIONAL JOURNAL OF HEALTH SCIENCES, 6(S2), 14663–14678. HTTPS://DOI.ORG/10.53730/IJHS.V6NS2.8876

PATEL, K. P., CHHALOTIYA, U. K., KACHHIYA, H. M., & PATEL, J. K. (2020). A NEW RP–HPLC METHOD FOR SIMULTANEOUS QUANTIFICATION OF PERINDOPRIL ERBUMINE, INDAPAMIDE, AND AMLODIPINE BESYLATE IN BULK AND PHARMACEUTICAL DOSAGE FORM. FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 6(1), 1-9.

PEKTAŞ, G., DINÇ, E., & BALEANU, D. (2009). COMBINED APPLICATION OF CONTINUOUS WAVELET TRANSFORM-ZERO CROSSING TECHNIQUE IN THE SIMULTANEOUS SPECTROPHOTOMETRIC DETERMINATION OF PERINDOPRIL AND INDAPAMID IN TABLETS. QUÍMICA NOVA, 32, 1416-1421. HTTPS://DOI.ORG/10.1590/S0100-40422009000600010.

PRAMEELA RANI, A. (2009). A VALIDATED RP-HPLC METHOD FOR THE DETERMINATION OF PERINDOPRIL ERBUMINE IN PHARMACEUTICAL FORMULATIONS, 1, 575-578.

SALEH, H. M., AMIN, A. S., & EL-MAMMLI, M. (2001). NEW COLORIMETRIC METHODS FOR THE DETERMINATION OF INDAPAMIDE AND ITS FORMULATIONS. MICROCHIMICA ACTA, 137(3), 185-189. HTTPS://DOI.ORG/10.1007/S006040170010.

SHARMA, R., & GUPTA, P. (2009). A VALIDATED RP-HPLC METHOD FOR SIMULATANEOUS ESTIMATION OF EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE IN A TABLET DOSAGE FORM. EURASIAN JOURNAL OF ANALYTICAL CHEMISTRY, 4(3), 276-284.

SIMONCIC, Z., ROSKAR, R., GARTNER, A., KOGEJ, K., & KMETEC, V. (2008). THE USE OF MICROCALORIMETRY AND HPLC FOR THE DETERMINATION OF DEGRADATION KINETICS AND THERMODYNAMIC PARAMETERS OF PERINDOPRIL ERBUMINE IN AQUEOUS SOLUTIONS. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 356(1-2), 200-205. DOI: 10.1016/J.IJPHARM.2008.01.031

SINGH, R., MAITHANI, M., SARAF, S. K., SARAF, S., & GUPTA, R. C. (2009). SIMULTANEOUS ESTIMATION OF CIPROFLOXACIN HYDROCHLORIDE, OFLOXACIN, TINIDAZOLE AND ORNIDAZOLE BY REVERSE PHASE–HIGH PERFORMANCE LIQUID CHROMATOGRAPHY. EURASIAN J. ANAL. CHEM, 4(2), 161-167.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949

TARKASE KAILASH, N., JADHAV MANISHA, B., TAJANE SACHIN, R., & DONGARE UMESH, S. (2012). DEVELOPMENT AND VALIDATION OF UV-SPECTROPHOTOMETRIC METHODS FOR ESTIMATION OF INDAPAMIDE IN BULK AND TABLET DOSAGE FORM. DER PHARMA CHEM, 4, 1128-1132.

TODD, P. A., & FITTON, A. (1991). PERINDOPRIL. DRUGS, 42(1), 90-114.

UNITED STATES PHARMACOPEIAL CONVENTION. U.S. PHARMACOPEIA-30–NATIONAL FORMULARY-25, ASIAN ED.; UNITED STATES PHARMACOPEIAL CONVENTION, INC.: ROCKVILLE, MD, USA, 2007; VOLUME II, P. 2340.

Published

11-08-2022

How to Cite

Mujawar, T., Ahmad, S., Khatik, S., Tare, M., Baheti, D., Gaikwad, A., & Ghangale, G. (2022). Development and validation of stability indicating RP-HPLC method for estimation of Perindopril Erbumine and Indapamide in bulk and pharmaceutical dosage form. International Journal of Health Sciences, 6(S6), 5159–5177. https://doi.org/10.53730/ijhs.v6nS6.11703

Issue

Section

Peer Review Articles